Abstract
Introduction

61
Human herpes simplex virus 1 (HSV-1; Family: Herpesviridae, Genus: Simplexvirus, species: 62
Human herpesvirus 1) has been recognized as a major human malady since the era of 63
Hippocrates (1), and to this day there is no effective vaccine (2). Approximately 50% of adults in 64
Finland are seropositive for HSV-1 (3-5), and 13% are seropositive for HSV-2 (3, 6). HSV 65 infects via epithelial or mucosal surfaces, after which it is taken up by nerve endings and 66 establishes a lifelong infection in neurons of the sensory or sympathetic nervous system. From 67 these neuronal sites the virus can reactivate, transit via nerve endings back to the skin surface, 68
and re-initiate skin or mucosal shedding at the same site as the original infection. In addition to 69 recurrent epithelial lesions, HSV also causes infectious keratitis, worsens acquisition and 70 shedding rates for human immunodeficiency virus (HIV), and can progress to cause rare but life-71 threatening encephalitis (1). 72
Recent comparative genomics studies of HSV-1, from our lab and others, have demonstrated that 73 HSV-1 strains from unrelated individuals can differ in 2-4% of the viral genome (7-13). HSV-1 74 has a large DNA genome of ~152 kilobases, encoding >75 proteins (14, 15). Sequence-based 75 comparisons of HSV-1 strains have demonstrated at least three major clades (16, 17), with 76 evidence of geographic clustering (9, 18), as well as recombination between these groups. HSV-77 1 displays greater host-to-host variation than any other alpha-herpesvirus (9, 19): approximately 78 double the amount found in HSV-2 (20, 21), and 5-fold higher than found between isolates of 79 varicella zoster virus (VZV) (22-24). The impacts of these naturally occurring viral genetic 80 variations on virulence and pathogenesis in humans are unknown. Examining the phenotypic 81 differences displayed by HSV-1 strains in culture provides an opportunity to explore the scope of 82 these differences and test whether or not they are linked to previously observed patterns of 83 geographic diversity. 84
Finland has a unique history that has led to a relatively homogeneous and stable population, 85 providing a unique view on the evolution of viruses that are persistent in the population. There 86 have been two major migratory sweeps contributing to expansion of the human population of 87
Finland: the first wave from the east, occurring ca. 4000 years ago, and another wave from the 88 south (southwest) ca. 2000 years ago (25-27). Finland also has one of the best genealogical 89 databases in the world, which in combination with computerized medical records and a high rate 90 of patient participation, has led to many recent advances in human medical genetics (28, 29) . 91
This may enable future studies to explore the co-evolution of human and viral genetic variation 92 in this population. 93 We have characterized ten HSV-1 strains isolated from a random subset of Finland clinic visits, 94 and compared their growth properties, drug resistance, and other phenotypic features. Full 95 genome sequences of these viruses were compared to each other and to other previously 96 described strains of HSV-1, to reveal patterns of inter-host and intra-host variability. We found 97 that the observed phenotypic differences did not partition into the same sub-groups as the overall 98 genomic patterns, demonstrating that whole-genome relatedness is not a proxy for viral 99 phenotype. We anticipate that these data will aid in efforts to develop improved sequence-based 100 antiviral therapies and contribute to development of a vaccine against HSV infections (30). 101
These data present an opportunity to explore the diversity of chronic herpesviruses in the Finland 102 population, and to lay the foundation for future studies that explore the connections betweenviral genetic differences, host genetic predispositions, and their potential relationship(s) to 104 clinical outcomes of HSV-1 infection. 105
106
Methods
107
Virus isolates and virus stock propagation
108
Clinical isolates were obtained from anonymous coded diagnostic samples from herpes lesions 109 representing currently circulating viral strains in Finland ( Table 1) . Approval for the study of 110 anonymous HSV isolates was provided by the Turku University Central Hospital (permit # 111
J10/17). 112
An immunoperoxidase-rapid culture assay (31) was used to type the viruses as HSV-1, which 113 was confirmed by a HSV type-specific gD (US6) gene-based PCR test (32). Viruses were 114 initially propagated on Vero cells (African green monkey kidney cells; ATCC), maintained in 115
Dulbecco's MEM with 2% fetal calf serum and gentamycin. A stock was made by addition of 3 116 ml of 9% autoclaved skimmed milk (Valio, Finland) on to 5 ml of the culture medium and 117 subsequent freezing. The cells and the medium were collected and combined upon thawing, and 118 were frozen and thawed for two further rounds before aliquoting. The viral titer was determined 119 by plaque titration on Vero cells as described before (33). Parallel aliquots were used for further 120 viral culture studies and for preparation of viral nucleocapsid DNA. For viral production data, 121 SPSS Statistics 20 (IBM, Armonk NY, USA) software was use to perform statistical analyses. 122
Non-parametric Mann-Whitney U-test was used to calculate statistical significances. The 123 threshold for significance was set to p<0.05. 124
Viral genomic DNA isolation
125
The viral genomic DNA was prepared from isolated viral nucleocapsids as described previously 126 (7, 34). In brief, viral stock collected from the first or second passage in Vero cells was used to 127 infect ~1x10 8 HaCaT cells (Department of Dentistry, University of Turku (35)) at a multiplicity 128 of infection (m.o.i.) of 0.1-1 plaque-forming units (PFU)/cell, and the infection was allowed to 129 proceed to completion at +35 °C (1-3 days). The cells were collected, washed with PBS and 130 suspended to LCM buffer (0.125 M KCl, 30 mM Tris pH 7.4, 5 mM MgCl2, 0.5 mM EDTA, 131 0.5% Nonidet P-40; with 0.6 mM beta-mercaptoethanol). After two successive extractions with 132
Freon (1,1,2-trichloro-1,2,2-trifluoroethane, Sigma-Aldrich), the extracts were added on top of 133 layers in LCM buffer with 45% and 5% glycerol and ultracentrifuged at 77 000 x g for 1 h at 134 University, Turku, Finland) were propagated in DMEM (high glucose) medium supplemented 145 with 10% fetal bovine serum, 2 mM L-glutamine and gentamycin. Initial differentiation of SH7 SY5Y cells involved culture for 10 days in DMEM/F-12 medium containing 5% fetal bovine 147 serum, 10 µM All-trans retinoic acid (Sigma), 2 mM L-glutamine and gentamycin. Thereafter 148 SH-SY5Y cells were transferred on Matrigel-coated (B-D) 96-well plates and the medium was 149 changed to serum-free DMEM/F-12 medium containing 10 µM all-trans retinoic acid (Sigma), 150 0.5 µg/ml of brain-derived neurotrophic factor (Millipore), 2 mM L-glutamine and gentamycin. 151
Acyclovir resistance testing
152
The sensitivity of each HSV strain to acyclovir was tested in a microplate format. Vero cells 153 grown on 96-well cell culture plates were treated with cell culture medium (DMEM with 5% 154 fetal bovine serum) supplemented with acyclovir (ACV; Sigma), in concentrations of 128 µg/ml 155 to 0.03125 µg/ml (1:4 serial dilutions). Duplicate wells containing each ACV dilution, and wells 156 without ACV, were infected with 100 PFU of each virus. As a control, the HSV-1 delta305 virus 157 was included; it is resistant to ACV due to deletion of its thymidine kinase gene (36). Infected 158 cells were incubated at +37 o C, at 5% CO2, for 72 hours before fixation with methanol and 159 staining with crystal violet. The reduction of plaque numbers at each ACV dilution was observed 160 in comparison with wells infected without ACV. A logistic fit curve was used for determination 161 of IC50 values. A virus with an IC50 value of over 2 µg/ml (of ACV) was considered resistant 162 (37). 163
Image acquisition
164
Photomicrographic images of viral plaques were obtained using a Zeiss Primovert inverted 165 microscope with Plan-Achromat 4x and 10x objectives, recorded using an AxioCam ERc 5s 166 camera, and analyzed using Zeiss ZEN 2012 software. A consensus viral genome for each strain was assembled using a de novo viral genome assembly 176 (VirGA) workflow (10). This approach begins with quality control, including removal of 177 contaminating host sequences, adapters from library preparation, and imaging artifacts. Next 178
Next generation sequencing
VirGA iterates through multiple de novo assemblies using SSAKE, which we then combine into 179 longer blocks of sequence (contigs) using Celera and GapFiller. VirGA uses Mugsy alignment to 180 match these contigs to the HSV-1 reference genome (strain 17, GenBank accession JN555585). 181
The best-matched contigs are stitched into a single consensus genome, which is then annotated 182 and subjected to additional quality control measures. These include an examination of coverage 183 (sequence read) depth, detection of minority variants within each consensus genome, and manual 184 inspection of gaps and low coverage areas. See Table 2 for GenBank accessions. 185
Intra-strain minority-variant detection
186
Minority-variant (MV) positions within each de novo assembled genome were determined using 187
VarScan v2.2.11 as previously described (38, 39). Conservative variant calling parameters toeliminate sequencing-induced errors were set at: minimum allele frequency ³0.02; base call 189 quality ³20; read depth at the position ³100; independent reads supporting minor allele ³5. GeneRuler mix DNA ladder, for 24 h at 45 V before imaging. In order to separate large DNA 216 fragments after SalI digestion, electrophoresis was continued for additional 36 h at 30 V. 217
218
Results
219
Comparison of growth properties of Finnish HSV-1 strains in vitro
220
A random set of ten circulating Finnish HSV-1 isolates were selected from residual laboratory 221 diagnostic specimens (Table 1) Table 1 ). There were also no significant differences among the 10 239 clinical isolates in the plaque morphology or the type of cytopathic effect induced in Vero cell 240 cultures (Figure 2) . 241
Genetic and genomic analysis of Finnish HSV-1 strains
242
Based on prior data suggesting the effects of successive waves of migration on the human 243 population in Finland (25, 26), we next assessed the overall genetic diversity of these ten HSV-1 244 isolates. We first performed a restriction fragment length polymorphism (RFLP) analysis on viral 245 genomic DNA, which revealed at least two broad patterns of variation (Figure 3 and 246 Supplemental Figure S2 ). The diversity of bands led us to examine these genetic differences 247 with greater precision using high-throughput, deep genome sequencing (HTS) and comparative 248 genomics analysis (see Methods for details). A previously described bioinformatics pipeline was 249 used to de novo assemble a full-length consensus genome for each strain (Table 2) . A viral 250 consensus genome represents the most common nucleotide detected at each nucleotide position 251
in that viral population. All viral genomes had a coverage depth between 1,000-2,800-fold, with>96% of the genome covered at a depth exceeding 100-fold (Table 2) alignments were created using the ten Finnish HSV-1 genomes, as well as these ten in 260 conjunction with a diverse set of previously published HSV-1 genomes (see Methods and 261
Supplemental Table S1 for a full list). We then used SplitsTree to create a network graph that 262 revealed the relatedness of the ten Finnish viral genomes to each other ( Figure 4A ) and to 263 previously described HSV-1 genomes ( Figure 4B ). This approach revealed that the Finland 264 HSV-1 genomes separated into two sub-groups, which appear to relate to previously recognized 265
Asian and European / North American clades. These data echo those of the initial RFLP analysis. 266
Protein-coding variation in Finland HSV-1 samples
267
Next, we examined more fine-scale genetic differences in these HSV-1 isolates, which are 268 invisible at the level of RFLP analysis. Here we examined DNA-and amino acid (AA)-269 alignments for each protein-coding region of the HSV-1 genome (Supplemental Table S2-S3) . 270 We found that from zero to 8% of each coding region differed at the AA level between the ten 271 Finnish viral genomes (Figure 5) . Only a handful of small coding regions (UL20, VP26 (UL35), 272 UL49A, UL55) showed no AA variation at all between viral isolates. Consistent with previousfindings (9), gL (UL1), UL11, UL43, gG (US4), and gJ (US5) were among the most divergent 274
proteins. Together these inter-strain genetic differences in 70 HSV-1 proteins in Figure 1D) . The terminally differentiated and non-dividing state of these neuronal cells 308 may constitute a sensitized background to detect impacts on virion egress. Taken together, these 309 examples illustrate the type and degree of variation present in these strains, and highlight 310 potential genetic insights into viral phenotype. 311
Discussion
313
In this study, we described the first-ever HSV-1 genomes from Finland. Two distinct sub-groups 314 or clades were observed in the ten Finnish clinical isolates, with four strains clustering in one 315 clade and six in another. These groups were detectable using both classical RFLP approaches 316 (Figure 3 ) and deep-sequencing methods for whole-genome analyses (Figure 4) . These data 317 appear to corroborate previous findings that show multiple colonization events of Finland, with 318 migration from Europe in the south and Asia in the northeast (25, 26). However, we found that 319 phenotypic differences between these isolates were uncoupled from the overall genomic patterns 320 that grouped them into two geographic clades. While plaque morphology was consistent across 321 isolates (Figure 2) , the amount of virus production, extracellular virion release, and acyclovir 322 sensitivity differed between isolates and across cell types (Figure 1 and Table 1 ). We detected 323 gene-specific patterns of genetic variation that may well impact protein function. Future studies 324 will need to dissect individual genetic variations in each viral isolate in order to test their precise 325 impact(s) on viral fitness. 326
When analyzing the replication capabilities of these recently isolated clinical samples in multiple 327 cell types, we found that they replicated to lower overall titers and produced fewer extracellular 328 virions than the lab-adapted HSV-1 strain 17+, regardless of cell type (Figure 1 and  329 Supplemental Figure S1 ). This difference was more pronounced in non-human primate and 330 human epithelial cells, and was more subtle in neuronal precursors and differentiated neuronal 331 cells. There did not appear to be any clear differences in titer or extracellular virus production 332 between geographic clades. There also seemed to be no noticeable differences in plaque 333 morphology among these samples, with plaque size and cellular cytopathic effect being similaracross all samples. Although we report findings in a number of cell lines in this study, it will be 335 important for future studies to examine each virus and cell-type pairing separately, since these 336 data demonstrate that maximal viral fitness in one cell type is not generally predictive of fitness 337 in another. 338
We observed several potential connections between genetic differences and phenotypic 339 differences. For instance, we detected an AA difference in the UL34 (NEC2) binding domain in 340 and for the reference strain HSV-1(17+) it was 0.13. The limit of resistance was >2.0 µg/ml. 546 isolates also represent the two sub-groups of Finnish HSV-1 isolates detected in Figures 3-4 , as 572 well as samples annotated as blister-derived (M-19) and genital-blister-derived (F-12g) (see also 573 Table 1 ). The scale bar corresponds to 100 µm in panels A and C, and to 50 µm in panels B and 574 
586
A network graph of genetic relatedness was constructed using SplitsTree4 to demonstrate how 587 the ten new Finland HSV-1 isolates relate to each other (A) and to previously described HSV-1 588 genomes from a diversity of locations (B). Geographic clustering of branches and clades 589 resemble those previously described (9, 16-18) and are colored by origin of strains: red for 590
Europe and North America, blue for Asia, and purple for Africa. Finland HSV-1 genomes are 591 indicated in bold, and separate into two sub-groups (A), which appear to relate previously 592 recognized Asian and European and North American clades. The isolate name, country of origin, 593
GenBank accession, and reference(s) for each previously described HSV-1 genome are listed in 594 Supplemental Table S1 . 
641
Histograms compare virus production for ten Finnish strains of HSV-1, as compared to the HSV-642 1 reference strain 17+, in different cell types. These data are the same as those shown in Figure  643 1, but here extracellular released virus, or shed virus (black), is plotted as a percentage of total 644 virus production (gray). Viruses are plotted in the same order as 
